443 related articles for article (PubMed ID: 30834874)
1. How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 90-90-90 target in the population on antiretroviral treatment in Khayelitsha, South Africa?
Euvrard J; Schulz T; Hilderbrand K; Bosland M; Osler M; Boulle A; Davies MA
S Afr Med J; 2019 Feb; 109(3):174-177. PubMed ID: 30834874
[TBL] [Abstract][Full Text] [Related]
2. Viral suppression among pregnant adolescents and women living with HIV in rural KwaZulu-Natal, South Africa: a cross sectional study to assess progress towards UNAIDS indicators and Implications for HIV Epidemic Control.
Ntombela NP; Kharsany ABM; Soogun A; Yende-Zuma N; Baxter C; Kohler HP; McKinnon LR
Reprod Health; 2022 May; 19(1):116. PubMed ID: 35550580
[TBL] [Abstract][Full Text] [Related]
3. Long-term virologic responses to antiretroviral therapy among HIV-positive patients entering adherence clubs in Khayelitsha, Cape Town, South Africa: a longitudinal analysis.
Kehoe K; Boulle A; Tsondai PR; Euvrard J; Davies MA; Cornell M
J Int AIDS Soc; 2020 May; 23(5):e25476. PubMed ID: 32406983
[TBL] [Abstract][Full Text] [Related]
4. HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa.
Teasdale CA; Sogaula N; Yuengling KA; Wang C; Mutiti A; Arpadi S; Nxele M; Pepeta L; Mogashoa M; Rivadeneira ED; Abrams EJ
J Int AIDS Soc; 2018 Aug; 21(8):e25168. PubMed ID: 30094952
[TBL] [Abstract][Full Text] [Related]
5. Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018.
Mhlanga TT; Jacobs BKM; Decroo T; Govere E; Bara H; Chonzi P; Sithole N; Apollo T; Van Damme W; Rusakaniko S; Lynen L; Makurumidze R
AIDS Res Ther; 2022 Jul; 19(1):34. PubMed ID: 35810317
[TBL] [Abstract][Full Text] [Related]
6. Viral load detection and management on first line ART in rural Rwanda.
Ndagijimana Ntwali JD; Decroo T; Ribakare M; Kiromera A; Mugwaneza P; Nsanzimana S; Lynen L
BMC Infect Dis; 2019 Jan; 19(1):8. PubMed ID: 30606128
[TBL] [Abstract][Full Text] [Related]
7. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
[TBL] [Abstract][Full Text] [Related]
8. Attrition Rates in HIV Viral Load Monitoring and Factors Associated With Overdue Testing Among Children Within South Africa's Antiretroviral Treatment Program: Retrospective Descriptive Analysis.
Haeri Mazanderani A; Radebe L; Sherman GG
JMIR Public Health Surveill; 2024 May; 10():e40796. PubMed ID: 38743934
[TBL] [Abstract][Full Text] [Related]
9. Progress towards the UNAIDS 95-95-95 targets among pregnant women in South Africa: Results from the 2017 and 2019 national Antenatal HIV Sentinel Surveys.
Woldesenbet S; Cheyip M; Lombard C; Manda S; Ayalew K; Kufa T; Puren A
PLoS One; 2022; 17(7):e0271564. PubMed ID: 35862306
[TBL] [Abstract][Full Text] [Related]
10. The HIV care cascade for adolescents initiated on antiretroviral therapy in a health district of South Africa: a retrospective cohort study.
Haghighat R; Toska E; Bungane N; Cluver L
BMC Infect Dis; 2021 Jan; 21(1):60. PubMed ID: 33435861
[TBL] [Abstract][Full Text] [Related]
11. Successes and challenges in optimizing the viral load cascade to improve antiretroviral therapy adherence and rationalize second-line switches in Swaziland.
Etoori D; Ciglenecki I; Ndlangamandla M; Edwards CG; Jobanputra K; Pasipamire M; Maphalala G; Yang C; Zabsonre I; Kabore SM; Goiri J; Teck R; Kerschberger B
J Int AIDS Soc; 2018 Oct; 21(10):e25194. PubMed ID: 30350392
[TBL] [Abstract][Full Text] [Related]
12. Viral load suppression after intensive adherence counselling among adult people living with HIV at Kiswa health centre, Kampala: a retrospective cohort study. Secondary data analysis.
Nakaye C; Mukiza N; Mawanda D; Kataike H; Kaganzi H; Ahimbisibwe GM; Businge GB; Kyambadde RC; Nakalega R
AIDS Res Ther; 2023 Mar; 20(1):18. PubMed ID: 36998004
[TBL] [Abstract][Full Text] [Related]
13. A nurse-led intervention to improve management of virological failure in public sector HIV clinics in Durban, South Africa: A pre- and post-implementation evaluation.
Sunpath H; Pillay S; Hatlen T; Murphy RA; Marconi VC; Moosa MS; Naidoo K; Siedner MJ
S Afr Med J; 2021 Mar; 111(4):299-303. PubMed ID: 33944759
[TBL] [Abstract][Full Text] [Related]
14. Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda.
Nakalega R; Mukiza N; Kiwanuka G; Makanga-Kakumba R; Menge R; Kataike H; Maena J; Akello C; Atuhaire P; Matovu-Kiweewa F; Ndikuno-Kuteesa C; Debem H; Mujugira A
BMC Infect Dis; 2020 Oct; 20(1):727. PubMed ID: 33023498
[TBL] [Abstract][Full Text] [Related]
15. When patients fail UNAIDS' last 90 - the "failure cascade" beyond 90-90-90 in rural Lesotho, Southern Africa: a
Labhardt ND; Ringera I; Lejone TI; Cheleboi M; Wagner S; Muhairwe J; Klimkait T
J Int AIDS Soc; 2017 Jul; 20(1):21803. PubMed ID: 28777506
[TBL] [Abstract][Full Text] [Related]
16. Maternal HIV viral load testing during pregnancy and postpartum care in Gauteng Province, South Africa.
Moyo F; Mazanderani AH; Kufa T; Sherman GG
S Afr Med J; 2021 Apr; 111(5):469-473. PubMed ID: 34852890
[TBL] [Abstract][Full Text] [Related]
17. Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.
Nicholas S; Poulet E; Wolters L; Wapling J; Rakesh A; Amoros I; Szumilin E; Gueguen M; Schramm B
J Int AIDS Soc; 2019 Aug; 22(8):e25387. PubMed ID: 31441242
[TBL] [Abstract][Full Text] [Related]
18. Evaluating facility-based antiretroviral therapy programme effectiveness: a pilot study comparing viral load suppression and retention rates.
Duber HC; Roberts DA; Ikilezi G; Fullman N; Gasasira A; Gakidou E; Haakenstad A; J Levine A; Achan J
Trop Med Int Health; 2016 Jun; 21(6):750-8. PubMed ID: 26996396
[TBL] [Abstract][Full Text] [Related]
19. HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.
Myer L; Phillips TK; McIntyre JA; Hsiao NY; Petro G; Zerbe A; Ramjith J; Bekker LG; Abrams EJ
HIV Med; 2017 Feb; 18(2):80-88. PubMed ID: 27353189
[TBL] [Abstract][Full Text] [Related]
20. Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy.
Kerschberger B; Boulle AM; Kranzer K; Hilderbrand K; Schomaker M; Coetzee D; Goemaere E; Van Cutsem G
J Int AIDS Soc; 2015; 18(1):20092. PubMed ID: 26403636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
